Clinical Characteristics and Management of Pyriform Sinus Fistula Infections in Children
Pediatrics International · 2026-01 · 68 (1)
DOI: 10.1111/ped.70595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 08.11.2026. Verfasst von Shina Tomono und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Pyriform Sinus, Anti-Bacterial Agents, Abscess, Fistula. Die Arbeit nennt 8 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Pyriform sinus fistula (PSF) is a congenital anomaly leading to recurrent cervical abscesses. Data on the clinical characteristics and methods of managing PSF infections in pediatric patients are scarce.
Methods
This retrospective study analyzed electronic medical records of patients under 15 years old diagnosed with PSF infection at Tokyo Metropolitan Children's Medical Center between March 2010 and August 2024. Diagnosis was based on clinical findings, imaging, hypopharyngeal esophagography, and surgical findings after inflammation resolution. Patients with revised diagnoses or those who declined participation were excluded, and multiple infections in the same patient were recorded as recurrences.
Results
Nineteen patients met the inclusion criteria; the median age at onset was 4 years (interquartile range [IQR]: 2–6 years), 58% were male, and most of the lesions were left‐sided (17 cases, 89%). The median duration of antimicrobial therapy was 31 days (IQR: 18–49 days), including a median duration of 7 days for intravenous therapy and 23 days for oral therapy. Ampicillin‐sulbactam was the most prescribed intravenous agent while amoxicillin‐clavulanic acid was frequently used for step‐down oral therapy. Drainage occurred in seven patients, including a puncture in five patients and spontaneous rupture in two patients. The most common pathogens were anaerobic bacteria. No treatment failures or recurrences were observed within 30 days after completion of treatment.
Conclusions
The median duration of antimicrobial therapy of 31 days may be sufficient to resolve acute PSF infections in children, provided that clinically appropriate surgical intervention is performed as required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
- Division of Infectious Diseases, Immunology, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
- Department of Surgery, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
ORCID-Profile: Shina Tomono, Yuto Otsubo, Akihiro Shimotakahara, Hiroshi Hataya, Yuho Horikoshi
Zitieren
APA
Tomono, S., Otsubo, Y., Shimotakahara, A., Hataya, H., & Horikoshi, Y. (2026). Clinical Characteristics and Management of Pyriform Sinus Fistula Infections in Children. Pediatrics International, 68(1). https://doi.org/10.1111/ped.70595
Vancouver
Tomono S, Otsubo Y, Shimotakahara A, Hataya H, Horikoshi Y. Clinical Characteristics and Management of Pyriform Sinus Fistula Infections in Children. Pediatrics International. 2026;68(1). doi:10.1111/ped.70595
BibTeX
@article{Tomono2026,
author = {Tomono, Shina and Otsubo, Yuto and Shimotakahara, Akihiro and Hataya, Hiroshi and Horikoshi, Yuho},
title = {Clinical Characteristics and Management of Pyriform Sinus Fistula Infections in Children},
journal = {Pediatrics International},
year = {2026},
volume = {68},
number = {1},
doi = {10.1111/ped.70595}
}
EUVIMED